Researchers from the Indiana University School of Medicine have developed a potential therapy for peripheral artery disease by transplanting autologous [the patient’s own] stem cells. In an animal model, the transplanted stem cells differentiated into new blood vessels, which then restored blood flow to damaged tissues in the body. Continue reading
Today, stem cells are rightfully perceived as the future of regenerative medicine, set to bring the marvels of science fiction into reality. But in looking ahead at all of the promise that stem cells hold for the future, it becomes easy to miss the scientific advances made to date for the millions of people around the world suffering from disease, trauma, and injury. Thus, today marks Stem Cell Awareness Day: a global celebration of stem cell research coordinated to highlight the treatments and therapies currently in development to create personalized regenerative therapies for patients. Continue reading
A team of researchers from John Hopkins University of Medicine have developed miniature human retinal tissue in vitro with the ability to detect light. The scientists, led by Assistant Professor M. Valena Canto-Soler, constructed a 3D model of the retinal tissue containing photoreceptor stem cells that form light sensitive tissue in the back of the eye. Continue reading
Jackie Ward, a PhD student at the University of California, San Diego, has devised a method for studying rare neurological diseases, such as spinocerebeller ataxia. Ward developed a disease-on-a-dish model by harvesting stem cells from ataxic patients, differentiating them into the type of cell that is degenerated by ataxia, and then studying the progression of the disease. Continue reading
A team of researchers at the University of Illinois led by doctors Fei Wang, Qiuhao Qu, and JianJun Cheng, have developed a fast and efficient technique for differentiating stem cells into motor neurons. The researchers added critical signaling molecules and growth factors to the cells much earlier than previous methods, resulting in twice the amount of neurons derived from the cells in half the time. Continue reading
In a recent Phase II clinical study, researchers report that mesenchymal stem cells were successful in relieving chronic lower back pain. The scientists injected MSCs directly into the degenerating vertebral disks of patients suffering from lower back pain, resulting in an overall reduction in the mean pain score, improved function for at least 12 months, and a reduced need for further surgical and non-surgical treatment interventions.
Of the 6 million Americans suffering from debilitating back pain today, 3.5 million are affected by degenerative invertebral disk disease. The results of this clinical trial show that, instead of addressing the symptoms, mesenchymal stem cells are able to treat the source of the pain for long lasting relief. According to lead researcher, Dr. Tory McJunkin, M.D, “This study shows we are progressing toward major advances in pain medicine,”
Mesenchymal stem cells have the unique capacity to regenerate a multitude of different types of tissues – such as neurons, insulin producing pancreatic beta cells, bone, cartilage, and cardiomyocites amongst them. This Phase II study is just one example of the utility of stem cells in successfully treating conditions previously thought to be untreatable or treatable only through invasive options. To learn how to bank your own valuable stem cells to insure access to emerging regenerative therapies, visit www.stemsave.com or call 877-783-6728 877-StemSave) today.
A team of scientists from Karlsruhe Institute of Technology, Max Planck Institute for Intelligent Systems, and the University of Tubingen have recently developed a prototype of artificial bone marrow. The bone marrow retains all of its basic properties, including the ability to regenerate hematopoietic stem cells, which can be used to treat patients with leukemia. Continue reading
Researchers at King’s County Hospital, London, have found that co-culturing hepatocytes [liver cells] with human mesenchymal stem cells [The same type found in Dental Stem Cells] improves hepatocyte survival and function. They found that in the presence of hepatocytes, the MSCs produced pro-survival factors, which supported the growth of the hepatocyte culture. Continue reading
A recent study from the Dana-Farber Cancer Institute has proven that stem cell transplants in myelodysplastic syndrome (MDS) patients were equally successful for patients age 71-74 as it was for patients age 60-65. According to Dr. Gregory Abel, an oncologist at Dana-Farber, “This is good evidence that age alone should not limit who should get a [stem cell] transplant for MDS.” Continue reading